THEMISMED NSE filing

Themis Medicare Promoters Declare No Share Encumbrance for FY26

The RealCase readLow impact Neutral

Themis Medicare promoters, including Dr. Dinesh S. Patel, declared no share encumbrance for FY26 under SEBI Takeover Regulations. Previous pledges by VIVIDHMARGI INVESTMENTS PRIVATE LIMITED in FY24 were already disclosed.

Why it matters

This is a routine compliance filing under SEBI Takeover Regulations, confirming the status quo regarding share encumbrances. It does not introduce any new material information that would significantly impact the company's stock or operations.

The market read

The announcement is a routine regulatory disclosure confirming no new encumbrances on shares. It does not contain any new positive or negative financial information or strategic developments.

Dr. Dinesh S. Patel, Promoter of Themis Medicare Limited, along with other promoters and persons acting in concert, has submitted a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. The disclosure confirms that no encumbrance has been made over the shares held by them during the financial year ended 31st March, 2026.

The announcement also notes that necessary disclosures regarding shares pledged by VIVIDHMARGI INVESTMENTS PRIVATE LIMITED during the financial year 2023-24 have already been made to the stock exchanges.

The promoters and promoter group entities listed in the disclosure include DINESH SHANTILAL PATEL, JAYSHREE DINESH PATEL, SACHIN DINESH PATEL, REENA SACHIN PATEL, ANAY RUPEN CHOKSI, VIVIDHMARGI INVESTMENTS PRIVATE LIMITED, NYSHA RUPEN CHOKSI, RUPEN ASHWIN CHOKSI, DINESH SHANTILAL PATEL (HUF), SHANTILAL DAHYABHAI PATEL(HUF), GEDEON RICHTER INVESTMENT MANAGEMENT LTD., VIVIDH DISTRIBUTORS PVT LTD, and THEMIS DISTRIBUTORS PRIVATE LIMITED.

The disclosure was submitted by Dr. Dinesh S. Patel from Mumbai on 02.04.2026.

Filing to action

What to do with a filing like this

Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.

View original filing